Novavax Advances Development of Novel COVID-19 Vaccine

Go back to Novavax Advances Development of Novel COVID-19 Vaccine
Novavax, Inc. (NASDAQ: NVAX) Delayed: 7.32 -0.12 (1.61%)
Previous Close $7.44    52 Week High $9.23 
Open $7.44    52 Week Low $1.16 
Day High $7.47    P/E N/A 
Day Low $7.22    EPS $-0.30 
Volume 3,403,336       

Novavax, Inc. (NASDAQ: NVAX) Delayed: 7.32 -0.12 (1.61%)
Previous Close $7.44    52 Week High $9.23 
Open $7.44    52 Week Low $1.16 
Day High $7.47    P/E N/A 
Day Low $7.22    EPS $-0.30 
Volume 3,403,336